3-Week radiation blast could spare seniors from 7 weeks of treatment
NCT ID NCT04284540
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a shorter radiation schedule (3 weeks instead of 6-7) for head and neck cancer in people aged 70 and older. The goal was to see if it could still control the cancer while reducing side effects and treatment gaps. 37 participants received either adjuvant or definitive hypofractionated radiation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiation therapy (hypofractionation)
What this could lead to
If successful, this shorter radiation schedule could make treatment easier for older patients and reduce side effects while still controlling the cancer.
What could go wrong
This is a small pilot study with only 37 participants, so results may not apply to everyone. The shorter schedule might not control the cancer as well as standard treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mount Sinai Chelsea
New York, New York, 10011, United States
-
Mount Sinai Downtown Union Square
New York, New York, 10003, United States
-
Mount Sinai Hospital
New York, New York, 10029, United States
-
Mount Sinai West
New York, New York, 10019, United States